Speech-Language Pathologists in Dunnellon, FL Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Suzanne Gaye Perry, MCD/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12080 Sw Highway 484, Dunnellon, FL 34432 Phone: 863-255-9325

Mrs. Saisha Marie Thomas, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13451 Se 98th St, Dunnellon, FL 34431 Phone: 831-247-9343

Ms. Amber Rae Anderson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8310 Sw 204th Ct, Dunnellon, FL 34431 Phone: 352-427-6579

News Archive

UMHS study finds premium rates affect where ob/gyns choose to practice

The high cost of malpractice insurance for some medical specialties affects not only how many doctors are entering the field of obstetrics and gynecology, but also where they offer their widely needed obstetric, prenatal and gynecological care, according to new University of Michigan Health System research.

House passes fraud bill to keep executives associated with wrongdoing from future Medicare business

The Hill's Healthwatch Blog: The House Wednesday passed a bill that would ban executives from "doing business with Medicare if their companies were convicted of fraud, even if the conviction takes place after their departure. The bill was introduced by the Ways and Means health panel's chairman and ranking member, Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.)."

Minimal dose computed tomography better at detecting new or recurrent lung cancer

Lung cancer is associated with very high mortality, in part because it is hard to detect at early stages, but also because it can recur frequently after surgical removal.

Natural blood ingredient prevents HIV

Scientists in Germany scientists say they have discovered a natural ingredient in human blood that prevents the HIV-1 virus from infecting immune cells.

Modified SARS-CoV-2 receptor-binding domain could increase vaccine efficacy, says study

A team of researchers from the USA and China have engineered a receptor-binding domain (RBD) that they claim improves the immunogenicity of multivalent SARS-CoV-2 vaccines. Their study, which was released on the bioRxiv* in November 2020, may help advance even more efficacious SARS-CoV-2 vaccine candidates in the future.

Read more Medical News

› Verified 6 days ago